• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Development of biomarker for detecting cartilage degradation in osteoarthritis].

作者信息

Kojima Toshihisa, Ishiguro Naoki

机构信息

Department of Orthopedic Surgery, Nagoya University School of Medicine.

出版信息

Nihon Rinsho. 2012 May;70(5):796-801.

PMID:22620003
Abstract

Now, It is becoming known that the mechanisms of cartilage matrix destruction such as roles of degradative enzymes including matrix metalloproteinase (MMP), aggrecanase, and cathepsin K and cytokines. For prevention of progression of cartilage destruction, it is important to develop the reliable biomarkers to detect the early stage of cartilage destruction. We reviewed the specific destructive products of type II collagen, major component of cartilage matrix, generated by collagenases and cathepsin K as well as those of aggrecan generated by MMPs and aggrecanase. The biomarker could be useful tool not only to understand the progression of joint destruction in osteoarthritis and rheumatoid arthritis but also to develop new treatment.

摘要

相似文献

1
[Development of biomarker for detecting cartilage degradation in osteoarthritis].
Nihon Rinsho. 2012 May;70(5):796-801.
2
[Bone and bone related biochemical examinations. Bone and collagen related metabolites. Biomarkers for cartilage matrix turnover and destruction in joint diseases].
Clin Calcium. 2006 Jun;16(6):1009-15.
3
Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.体外软骨聚集蛋白聚糖球间结构域分解代谢中聚集蛋白聚糖酶与基质金属蛋白酶的比较
Biochem J. 1999 Nov 15;344 Pt 1(Pt 1):61-8.
4
Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.人软骨中的聚集蛋白聚糖降解。正常、骨关节炎和类风湿性关节中基质金属蛋白酶和聚集蛋白聚糖酶活性的证据。
J Clin Invest. 1997 Jul 1;100(1):93-106. doi: 10.1172/JCI119526.
5
Bone sialoprotein in laboratory diagnostic work-up of osteoarthritis.
Ortop Traumatol Rehabil. 2008 May-Jun;10(3):211-7.
6
Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.人类炎症性关节炎发病时软骨基质中Ⅱ型胶原蛋白和聚集蛋白聚糖的周转:与全身和局部炎症介质的关系。
Arthritis Rheum. 2003 Nov;48(11):3085-95. doi: 10.1002/art.11331.
7
Inhibition of interleukin-1alpha-induced cartilage oligomeric matrix protein degradation in bovine articular cartilage by matrix metalloproteinase inhibitors: potential role for matrix metalloproteinases in the generation of cartilage oligomeric matrix protein fragments in arthritic synovial fluid.基质金属蛋白酶抑制剂对白细胞介素-1α诱导的牛关节软骨中软骨寡聚基质蛋白降解的抑制作用:基质金属蛋白酶在关节炎滑液中软骨寡聚基质蛋白片段生成中的潜在作用。
Arthritis Rheum. 1998 Dec;41(12):2143-51. doi: 10.1002/1529-0131(199812)41:12<2143::AID-ART9>3.0.CO;2-P.
8
[Research progress of biomarker COMP in osteoarthritis].骨关节炎生物标志物COMP的研究进展
Zhongguo Gu Shang. 2010 Dec;23(12):959-61.
9
Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).在培养的骨关节炎软骨中选择性增强胶原酶介导的驻留II型胶原的裂解,并使用一种对胶原酶1(基质金属蛋白酶1)无影响的合成抑制剂来阻止这种裂解。
Arthritis Rheum. 2000 Mar;43(3):673-82. doi: 10.1002/1529-0131(200003)43:3<673::AID-ANR25>3.0.CO;2-8.
10
Biomarkers of cartilage turnover. Part 2: Non-collagenous markers.软骨转换生物标志物。第 2 部分:非胶原蛋白标志物。
Vet J. 2010 Jul;185(1):43-9. doi: 10.1016/j.tvjl.2010.04.012. Epub 2010 May 21.